Feb. 19, 2017:
Just out of the starting blocks of 2017, the Big Ten Cancer Centers are already vaulting over more than $30 million of impressive grants, awards, and gifts, long jumping into new leadership positions and appointments, and crossing the finish line of multiple pace-setting studies. In this month’s edition of Across the Consortium, we recap recent highlights of this winning relay team, the Big Ten CRC!
Feb. 9, 2017 The University of Illinois at Chicago has named Oana Danciu, MD, its representative to the Big Ten Cancer Research Consortium Steering Committee. Dr. Danciu is assistant professor of medicine in the Division of Hematology and Oncology at UIC, and serves as interim director of UIC’s Clinical Trials Office. She specializes in the treatment of patients with breast cancer. Her research interests include development of clinical trials using experimental therapeutics. She is working on identifying molecular pathways and predictive biomarkers for different subtypes of breast cancer. Dr. Danciu received her medical degree from Carol Davila University in Bucharest,...
Feb. 4, 2017: Whether a basic scientist is driven to the clinic to share discoveries or a clinician is driven to the lab in search of answers, frontiers in oncology traverse two worlds: the lab and the clinic. Some researchers, like Sheldon L. Holder, MD, PhD, of the Penn State Cancer Institute, a member of the Big Ten Cancer Research Consortium, embody the best of both worlds. Through bold curiosity, teamwork, and an interdisciplinary perspective that not only solves problems, but does so with purpose, Holder exemplifies the Big Ten CRC’s commitment to engaging basic scientists in the development of clinical trials. An empowered curiosity Holder grew up on the Island of Bermuda, where his interest in medicine was sparked. “It began very early, almost as far back as I can remember. In second grade I...
Jan. 23, 2017: The Big Ten Cancer Research Consortium's “Across the Consortium” is your all-access pass to the latest action in cancer research conducted by our member institutions. We begin a new year with recent highlights from each member institution. Here’s to a promising new year across the consortium! Read More
Jan. 1, 2017: Investigator Spotlight Nasser Hanna, MD Educational Background: BA in biology from St. Louis University; MD from University of Missouri-Columbia Research Interests: My research interests are in the areas of lung cancer and testicular cancer. My lung cancer research has focused on the treatment of stage III and IV non-small cell lung cancer and extensive stage small cell lung cancer. I have led multiple phase II and III clinical trials in each of these disease states. I am also interested in studying novel therapies in the refractory setting of men with testicular cancer. Fun Facts: I love watching open wheel racing. I played competitive tennis in high school. I have four children.
Dec. 29, 2016: Members of the Big Ten Cancer Research Consortium Steering Committee recently appointed Robert Kratzke, MD, as the committee's first chair, and Ruth O'Regan, MD, as its vice chair. Each will serve a one-year term, with Dr. O'Regan serving as chair in the subsequent year. Read More
Dec. 21, 2016: Fast away the old year passes, and the Big Ten Cancer Centers are bringing 2016 to a climactic close. Their amazing and world-changing work in the fight against cancer has not only made 2016 an unforgettable and truly historic year, but it also beckons the shining dawn of a promising new year full of hope for patients and researchers. Next year’s breakthroughs have been this year’s vision, and this year’s legacy becomes next year’s inspiration. Take a moment to reflect on recent breakthroughs which embody a year to remember, in 2016’s final Across the Consortium. Read More
Dec. 19, 2016: Andrea L. Kasinski, PhD Investigator Spotlight Andrea L. Kasinski, PhD Educational Background: PhD, Emory University (2009), Postdoctoral Fellow, Yale University Research Interests: My laboratory works on non-coding RNA biology and therapeutics. Specifically, we focus on identifying biologically important RNAs whose misexpression drives the tumorigenic process. We then utilize this information to design, develop, and implement RNA-based therapeutics. Specifically, evidence-based approaches are being developed to identify microRNAs that drive the process of tumorigenesis, or to identify microRNAs that are required for tumor cell maintenance or therapeutic resistance. Using this data, we then develop various strategies to alter the concentration of theses microRNAs in...
Nov. 21, 2016: Patients with locally advanced bladder cancer often find themselves at a fork in the road when it comes to treatment decisions. The determining factor for many patients is whether or not they are candidates for surgery. For those who can have cisplatin based chemotherapy and can undergo surgery, the standard approach is often well defined; but for those who cannot, the road ahead is not so clear. A new Big Ten Cancer Research Consortium study, led by Monika Joshi, MD, MRCP, of Penn State Cancer Institute, may help to open new options for these patients. Read More
Nov. 18, 2016: In the season of gratitude, this month's edition of Across the Consortium recounts more reasons to be grateful for the collegial partnership of the Big Ten Cancer Centers in the fight against cancer. Get up to date on the stunning discoveries and monumental breakthroughs with far-reaching implications. Be inspired by accounts of leadership. Remember why we are stronger together. All this and more as we take you Across the Consortium! Read More
University of Illinois
Indiana University
University of Iowa
University of Maryland
University of Michigan
Michigan State
University of Minnesota
University of Nebraska
Northwestern University
Penn State University
Purdue University
Rutgers State University
University of Wisconsin
University of Illinois at Chicago
© 2024 All rights reserved.
Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube